Analyst Ratings for Avalanche Biotechnologies (AAVL)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/17/2015 | Chardan | N/A | Upgrade | Buy (Neutral) |
N/A (N/A) |
10.01 (4.14) |
-58.64% | Details |
| 6/16/2015 | William Blair | N/A | Downgrade | Market Perform (Outperform) |
24.00 (53.00) |
38.88 (4.14) |
-89.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
